- R
Rarebase
- John Lee
John Lee is a seasoned professional with extensive experience in investment and management roles. Currently serving as a Partner at JAZZ Venture Partners, John also holds the position of Executive Chairman at Transcripta Bio and is a Principal at Osage University Partners. Previous experience includes roles as an Investor at Lux Capital and Manager at Mahindra & Mahindra. John Lee's academic background includes a Bachelor of Science degree with a major in Biology and minors in Economics and Nutrition from Cornell University, attended from 2006 to 2010, following high school education at St. Xavier High School from 2002 to 2006.
Org chart
Teams
This person is not in any teams
Offices
Rarebase
Rarebase is enabling a better life for the 400 million people living with rare disease. With a product engine designed to discover treatments for hundreds of monogenic diseases simultaneously, Rarebase is focused on the largest untapped drug discovery opportunity in human health: rare diseases. Rarebase has already uncovered potential treatments for hundreds of rare diseases. The company has also built a “drug-gene atlas” to enable AI-driven drug discovery.
